Icrucumab, a fully human monoclonal antibody against the vascular endothelial growth factor receptor-1, in the treatment of patients with advanced solid malignancies: a Phase 1 study

Author： LoRusso Patricia   Krishnamurthi Smitha   Youssoufian Hagop   Hall Nancy   Fox Floyd   Dontabhaktuni Aruna   Grebennik Dmitri   Remick Scot  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.32, Iss.2, 2014-04, pp. : 303-311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Dual inhibition of the vascular endothelial growth factor pathway: A phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors

By Hong David S.   Garrido-Laguna Ignacio   Ekmekcioglu Suhendan   Falchook Gerald S.   Naing Aung   Wheler Jennifer J.   Fu Siqing   Moulder Stacy L.   Piha-Paul Sarina   Tsimberidou Apostolia M.   Wen YueJin   Culotta Kirk S.   Anderes Kenna   Davis Darren W.   Liu Wen   George Goldy C.   Camacho Luis H.   Percy Ivy Susan   Kurzrock Razelle  

Cancer, Vol. 120, Iss. 14, 2014-07 ,pp. : 2164-2173

Blackwell Publishing

Access to resources Recommend Favorite

Cetuximab: an IgG1 monoclonal antibody for the treatment of epidermal growth factor receptor-expressing tumours

By Humblet Yves  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 7, 2004-07 ,pp. : 1621-1633

Informa Healthcare

Access to resources Recommend Favorite

A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study

By Pappo Alberto S.   Vassal Gilles   Crowley John J.   Bolejack Vanessa   Hogendoorn Pancras C. W.   Chugh Rashmi   Ladanyi Marc   Grippo Joseph F.   Dall Georgina   Staddon Arthur P.   Chawla Sant P.   Maki Robert G.   Araujo Dejka M.   Geoerger Birgit   Ganjoo Kristen   Marina Neyssa   Blay Jean-Yves   Schuetze Scott M.   Chow Warren A.   Helman Lee J.  

Cancer, Vol. 120, Iss. 16, 2014-08 ,pp. : 2448-2456

Blackwell Publishing

Access to resources Recommend Favorite

Co-Expression of Vascular Endothelial Growth Factor and Interleukin-1 Receptor Antagonist Improves Human Islet Survival and Function

By Narang Ajit   Sabek Omaima   Gaber Ahmed   Mahato Ram  

Pharmaceutical Research, Vol. 23, Iss. 9, 2006-09 ,pp. : 1970-1982

Springer Publishing Company

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor and Its Receptor as Drug Targets in Hematological Malignancies

By  

Current Drug Targets, Vol. 8, Iss. 2, 2007-02 ,pp. : 257-268

Bentham Science Publishers

Access to resources Recommend Favorite